Brief: Cohance Lifesciences To Sell CR Bio Unit For 160 Mln Rupees
20/06/2025 07:48
June 20 (Reuters) - Cohance Lifesciences Ltd COHA.NS: TO SELL CR BIO UNIT FOR 160 MILLION RUPEES SALE EXPECTED TO COMPLETE IN Q2 FY2026 Source text: ID:nBSEbdc5cH Further company coverage: COHA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss